NEUROPACE INC
NPCENASDAQTrading Snapshot
- Day Range
- $14.47 – $14.89
- 52-Week Range
- $7.56 – $19.60
- Volume
- $3.35B
- Avg Volume
- $3.26B
- Shares Outstanding
- 34.1M
- Next Earnings
- Oct 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $100M
- Last Q Revenue
- $23M
- P/E Ratio
- —
- P/S Ratio
- 5.1x
- EPS (TTM)
- $-0.65
- Dividend Yield
- —
Why Investors Own NPCE
- ✓High-growth profile — revenue up +8.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 47% gross margin and 5% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About NEUROPACE INC
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares moved
Avis Budget Posts Weak Q2 Results, Joins Fiverr International, Costar Group And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
US stock futures mixed, Dow up 0.1%. Avis Budget Group (CAR) shares down 13.3% after missing earnings & sales estimates. Other stocks also down.
HC Wainwright & Co. Reiterates Buy on NeuroPace, Maintains $20 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates NeuroPace (NASDAQ:NPCE) with a Buy and maintains $20 price target.
NeuroPace, Inc. (NPCE) Discusses FDA Feedback on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy Transcript
NeuroPace, Inc. (NPCE) Discusses FDA Feedback on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy July 28, 2026 4:30 PM...
These stocks are moving in today's after hours session
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 million. CalciMedica (NASDAQ:CALC) shares rose 9.8%